Major Depressive Disorder is Associated with Impaired Mitochondrial Function in Skin Fibroblasts
Authors:
- Kerstin KuffnerKKKerstin Kuffner
- Julian TriebelhornJTJulian Triebelhorn
- Katrin MeindlKMKatrin Meindl
- Christoph BennerCBChristoph Benner
- André ManookAMAndré Manook
- Daniel Sudria-LopezDSDaniel Sudria-Lopez
- Ramona SiebertRSRamona Siebert
- Caroline NothdurfterCNCaroline Nothdurfter
- Thomas C. BaghaiTBThomas C. Baghai
- Konstantin DrexlerKDKonstantin Drexler
- Mark BerneburgMBMark Berneburg
- Rainer RupprechtRRRainer Rupprecht
Open Access
Abstract
Mitochondrial malfunction is supposed to be involved in the etiology and pathology of major depressive disorder (MDD). Here, we aimed to identify and characterize the molecular pathomechanisms related to mitochondrial dysfunction in adult human skin fibroblasts, which were derived from MDD patients or non-depressive control subjects. We found that MDD fibroblasts showed significantly impaired mitochondrial functioning: basal and maximal respiration, spare respiratory capacity, non-mitochondrial respiration and adenosine triphosphate (ATP)-related oxygen consumption was lower. Moreover, MDD fibroblasts harbor lower ATP levels and showed hyperpolarized mitochondrial membrane potential. To investigate cellular resilience, we challenged both groups of fibroblasts with hormonal (dexamethasone) or metabolic (galactose) stress for one week, and found that both stressors increased oxygen consumption but lowered ATP content in MDD as well as in non-depressive control fibroblasts. Interestingly, the bioenergetic differences between fibroblasts from MDD or non-depressed subjects, which were observed under non-treated conditions, could not be detected after stress. Our findings support the hypothesis that altered mitochondrial function causes a bioenergetic imbalance, which is associated with the molecular pathophysiology of MDD. The observed alterations in the oxidative phosphorylation system (OXPHOS) and other mitochondria-related properties represent a basis for further investigations of pathophysiological mechanisms and might open new ways to gain insight into antidepressant signaling pathways.Keywords
All Related Versions
Funding Information
- Deutsche Forschungsgemeinschaft (422182557, WE2298, GRK2174)
- Else Kröner-Fresenius-Stiftung (K.D.)
- Bundesministerium für Forschung, Technologie und Raumfahrt (01EE1401B)
This publication has 42 references indexed in Scilit:
- Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressorsTranslational Psychiatry, 2015
- A mitochondrial bioenergetic basis of depressionJournal of Bioenergetics and Biomembranes, 2014
- Cellular aging in depression: Permanent imprint or reversible process?BioEssays, 2014
- Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depressionTranslational Psychiatry, 2014
- Mitochondrial respiration in blood platelets of depressive patientsMitochondrion, 2013
- Gene—Environment Interactions in Major Depressive DisorderThe Canadian Journal of Psychiatry, 2013
- Impaired mitochondrial function in psychiatric disordersNature Reviews Neuroscience, 2012
- Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disordersProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- PATHOPHYSIOLOGY OF DEPRESSION: DO WE HAVE ANY SOLID EVIDENCE OF INTEREST TO CLINICIANS?World Psychiatry, 2010
- Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patientsJournal of Affective Disorders, 2003